iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens [Yahoo! Finance]
iSpecimen Inc. (ISPC)
Company Research
Source: Yahoo! Finance
online marketplace for human biospecimens, today announced its strategic initiatives for 2025, expanding services to procure high demand cancer biospecimens, enhancing its ability to support groundbreaking cancer research worldwide. The demand for cancer tissue continues to grow as cancer remains a significant area of focus in medical research and investment. Market reports indicate that cancer accounts for a substantial growing percentage of biospecimen sales, highlighting the critical need for reliable access to high-quality specimens. iSpecimen is poised to address this need through expanded partnerships with access to genomic sequencing, and a data-driven approach. To meet the growing demand, iSpecimen plans to pursue new partnerships with U.S.-based cancer centers. These collaborations will increase access to domestic cancer blood products, enabling researchers to obtain the specimens they need more efficiently. This initiative aligns with the company's broader strategic focu
Show less
Read more
Impact Snapshot
Event Time:
ISPC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ISPC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ISPC alerts
High impacting iSpecimen Inc. news events
Weekly update
A roundup of the hottest topics
ISPC
News
- iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 AnnuallyGlobeNewswire
- iSpecimen Reports Third Quarter 2024 ResultsGlobeNewswire
- iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
- iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
- iSpecimen files to sell 1.2M shares of common stock [Seeking Alpha]Seeking Alpha
ISPC
Sec Filings
- 12/20/24 - Form 8-K
- 12/13/24 - Form 3
- 12/13/24 - Form 8-K
- ISPC's page on the SEC website